EUVIMEDEUVIMED entdecken
Crossref

Intralesional Methotrexate versus Intralesional Triamcinolone acetonide in Treatment of Resistant Localized Alopecia Areata

Ahmed Mohammad Abdel Aal, Ahmed Shawky Abdelaty, Alshaimaa Abdullah Muhammad

Al-Azhar International Medical Journal · 31.03.2025 · 2025 (3) · 122-128

DOI: 10.21608/aimj.2025.446474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Azhar International Medical Journal, online erschienen am 31.03.2025. Verfasst von Ahmed Mohammad Abdel Aal und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Aal, A. M. A., Abdelaty, A. S., & Muhammad, A. A. (2025). Intralesional Methotrexate versus Intralesional Triamcinolone acetonide in Treatment of Resistant Localized Alopecia Areata. Al-Azhar International Medical Journal, 2025(3), 122-128. https://doi.org/10.21608/aimj.2025.446474

Vancouver

Aal AMA, Abdelaty AS, Muhammad AA. Intralesional Methotrexate versus Intralesional Triamcinolone acetonide in Treatment of Resistant Localized Alopecia Areata. Al-Azhar International Medical Journal. 2025;2025(3):122-128. doi:10.21608/aimj.2025.446474

BibTeX
@article{Aal2025,
  author = {Aal, Ahmed Mohammad Abdel and Abdelaty, Ahmed Shawky and Muhammad, Alshaimaa Abdullah},
  title = {Intralesional Methotrexate versus Intralesional Triamcinolone acetonide in Treatment of Resistant Localized Alopecia Areata},
  journal = {Al-Azhar International Medical Journal},
  year = {2025},
  volume = {2025},
  number = {3},
  pages = {122--128},
  doi = {10.21608/aimj.2025.446474}
}
Kostenlos starten →